Sanara MedTech sold all assets of Tissue Health Plus, a wholly owned subsidiary, on Oct. 6. The assets included Tissue Health Plus’s business software products and related intellectual property. The buyer was an unrelated third party.
The sale price was approximately $2 million, and Sanara also received earnout rights tied to the transaction. The company did not provide details about the earnout terms.
- What changed: Sanara has divested Tissue Health Plus’s assets, including its software products and intellectual property.
- What Sanara received: Approximately $2 million in purchase price, plus earnout rights that may provide additional value under terms not specified.
- Ownership and control: The buyer is unrelated to Sanara; the sale covered all of Tissue Health Plus’s assets. The announcement did not describe any other changes to Sanara’s business or management.
The transaction removes Tissue Health Plus’s assets from Sanara’s portfolio while leaving the company with potential additional proceeds through the earnout rights.